Related Experiment Videos
[Amoxicillin preparation with prolonged activity (author's transl)]
Abstract:
This study was performed to develop a prolonged acting preparation on the bases of our in vitro study of AMPC that the bacterial effects of AMPC were not proportional to the concentration of and above MIC but to the exposing time. A desirable serum level was obtained in the AMPC preparation containing 30% of non-coated granules and 70% of enteric-coated granules dissolvable on and above pH 6. The duration time of the serum concentration on and above 2.5 micrograms/ml in the administration of this preparation (500 mg (Potency)) was 5.3 hours and it was 2.4 times that of the conventional capsule (250 mg (Potency)). The prolonged activity of this preparation was also observed in the urinary concentration. These results suggest that this prolonged action granules of AMPC could reduce the administration frequency and also might be more useful in increasing therapeutic effects than conventional capsule.
Insights
This study developed a new prolonged-acting ampicillin (AMPC) preparation. This formulation enhances therapeutic efficacy by extending drug exposure time, reducing administration frequency.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Microbiology
Context:
- Bacterial infections require effective antibiotic treatment.
- Antibiotic efficacy is often linked to drug concentration and exposure time.
- Developing sustained-release formulations can improve therapeutic outcomes.
Purpose:
- To develop a prolonged-acting ampicillin (AMPC) preparation based on in vitro findings.
- To achieve desired serum and urinary concentrations for extended periods.
- To enhance the therapeutic potential of AMPC compared to conventional formulations.
Summary:
- A novel AMPC preparation was created using a blend of non-coated and enteric-coated granules (pH 6).
- This formulation achieved a serum concentration above 2.5 µg/ml for 5.3 hours, 2.4 times longer than conventional capsules.
- Prolonged activity was also noted in urinary concentrations, indicating sustained drug availability.
Impact:
- The prolonged-acting AMPC preparation may reduce dosing frequency.
- This formulation has the potential for increased therapeutic effects in treating bacterial infections.
- Sustained drug delivery systems offer improved patient compliance and treatment efficacy.